Cancer Treatment Foundation: Estonian Health Insurance Fund takes over funding of six anticancer drugs from donors

Since 1 January the Estonian Health Insurance Fund has been compensating six modern anticancer drugs, which people previously had to purchase relying on the help of the Cancer Treatment Foundation and other charitable funds.


The medicines are for the treatment of lung, bone marrow, stomach, oesophageal and kidney tumours, lymphoma and leukaemia. According to the Health Insurance Fund, around 200 people per year require these specific medicines.


"We welcome the fact that these treatments, which to date people have had to rely on the help of donors in order to buy, are now being covered under state health insurance,” said Toivo Tänavsuu, the head of the cancer treatment foundation ‘The Gift of Life’. “Four out of six drugs are known to us here at the foundation. Over time we’ve purchased these medications for many people, thereby helping them to escape the abyss that the non-funding of the drugs would otherwise have left them in."


The following anti-cancer medicines have been compensated by the Health Insurance Fund since the start of the year:

- DARZALEX: for the treatment of multiple myeloma in adult patients

- KEYTRUDA: for metastatic non-small cell lung cancer patients and patients with Hodgkin's lymphoma. The fund has helped many patients with different diagnoses obtain this medication. Some of them are now getting treatment at the cost of the Health Insurance Fund; others continue to have to rely on the support of the Cancer Treatment Foundation.

- ZYKADIA: for patients with metastatic non-small cell lung cancer

- XTANDI: for the treatment of metastatic prostate cancer. This medicine has been known to the foundation since 2015.

- QARZIBA: for the treatment of high-risk neuroblastoma. This is the medication which 8-year-old Annabel and 6-year-old Tauris obtained with the support of the fund, both of whom were declared free from the disease in spring 2018. ‘The Gift of Life’ and the Estonian Association of Parents of Children with Cancer, the organiser of the charity Duck Rally, contributed almost 250,000 euros to the treatment of the two children.

- BLINCYTO: for patients with lymphoblastic leukaemia. 35-year-old mother Maily was able to obtain this exorbitantly priced drug with the help of the fund in early 2018, but sadly succumbed to her illness.


Cancer Treatment Foundation to receive 115,000-euro operating grant from the state
At the beginning of the year, the cancer treatment foundation will receive 115,000 euros from the 2019 state budget as an operating grant, or so-called political protection money. This is half of the amount the foundation paid in medication VAT last year.
16.01.2019
Almost half a million euros donated to Cancer Treatment Foundation in December
The Cancer Treatment Foundation received over 465,000 euros in donations in December. Never before has the amount of donations made in one month been so high.
10.01.2019
Cancer Treatment Foundation: Estonian Health Insurance Fund takes over funding of six anticancer drugs from donors
Since 1 January the Estonian Health Insurance Fund has been compensating six modern anticancer drugs, which people previously had to purchase relying on the help of the Cancer Treatment Foundation and other charitable funds.
10.01.2019